Expression of bone morphogenetic protein-2 and its receptors in epithelial ovarian cancer and their influence on the prognosis of ovarian cancer patients
<p>Abstract</p> <p>Background</p> <p>To determine the expression of bone morphogenetic protein-2 (BMP-2) and its receptors BMPRIA, BMPRIB, and BMPRII in epithelial ovarian cancer (EOC) and to analyze their influence on the prognosis of ovarian cancer patients.</p>...
Main Authors: | Guo Quan, Ma Lin, Ma Ying, Zhang Shulan |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-06-01
|
Series: | Journal of Experimental & Clinical Cancer Research |
Online Access: | http://www.jeccr.com/content/29/1/85 |
Similar Items
-
The role of bone morphogenetic protein 2 in ovarian cancer migration
by: Lau, Kevin Soon-Keen
Published: (2016) -
Expression of PAWR predicts prognosis of ovarian cancer
by: Jiahong Tan, et al.
Published: (2020-12-01) -
Modulation of bone morphogenetic protein activity by melatonin in ovarian steroidogenesis
by: Fumio Otsuka
Published: (2018-07-01) -
Increased expression of protein kinase CK2α correlates with poor patient prognosis in epithelial ovarian cancer.
by: Zebiao Ma, et al.
Published: (2017-01-01) -
Chemokine Receptors in Epithelial Ovarian Cancer
by: Goda G. Muralidhar, et al.
Published: (2013-12-01)